BIIB

Biogen Idec Inc. Competitors

$205.63
*  
5.17
  negative  
2.45%
Get BIIB Alerts
*Delayed - data as of Jun. 19, 2013 15:22 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIIB Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Biogen Idec Inc.
CompanyName
Symbol : Market
LastSale NetChange Volume Today's High/ Low 52 Weeks High/ Low P/ERatio Market Cap
Vical Incorporated
VICL: NASDAQ-GS
$ 3.13 0.05   760,188 $ 3.17
$ 3.10
$ 4.74
$ 2.61
NE 269,956,240
TrovaGene, Inc.
TROVW: NASDAQ-CM
$ 4.04 -0.04   6,271 $ 4.14
$ 3.44
$ 4.44
$ .2001
NE 4,646,000
TrovaGene, Inc.
TROVU: NASDAQ-CM
$ 15.47 unch n/a
n/a
$ 21.30
$ 4.56
NE 17,790,500
TrovaGene, Inc.
TROV: NASDAQ-CM
$ 6.49 0.08   59,711 $ 6.49
$ 6.30
$ 8.96
$ 2.09
NE 101,347,840
Techne Corporation
TECH: NASDAQ-GS
$ 68.26 0.05   111,369 $ 68.80
$ 68.07
$ 76.02
$ 62.55
22.53 2,514,834,920
StemCells, Inc.
STEM: NASDAQ-CM
$ 1.6901 -0.08   603,004 $ 1.79
$ 1.68
$ 2.67
$ .621
NE 63,277,344
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 7.93 -0.25   292,699 $ 8.25
$ 7.86
$ 11.24
$ 4.77
NE 423,089,290
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 31.615 -0.59   269,461 $ 32.40
$ 31.37
$ 39
$ 21.05
NE 3,807,647,370
Repros Therapeutics Inc.
RPRXZ: NASDAQ-CM
$ 18 3.61   100 $ 18
$ 18
$ 37.68
$ 8
NE 15,408,000
Repros Therapeutics Inc.
RPRXW: NASDAQ-CM
$ 14.72 unch n/a
n/a
$ 39.99
$ 11.23
NE 12,909,440
Repros Therapeutics Inc.
RPRX: NASDAQ-CM
$ 19.17 -0.02   617,102 $ 21.02
$ 19
$ 20.78
$ 7.795
NE 328,113,720
Repligen Corporation
RGEN: NASDAQ-GS
$ 7.66 -0.26   145,424 $ 7.9399
$ 7.60
$ 9.65
$ 3.78
15.96 238,317,920
Qiagen N.V.
QGEN: NASDAQ-GS
$ 19.63 0.01   448,837 $ 19.85
$ 19.52
$ 22.20
$ 15.90
39.26 4,642,239,810
Pluristem Therapeutics, Inc.
PSTI: NASDAQ-CM
$ 2.69 -0.10   241,247 $ 2.80
$ 2.68
$ 5
$ 2.26
NE 157,738,910
Protalix BioTherapeutics, Inc.
PLX: AMEX
$ 5.19 0.11   1,085,829 $ 5.45
$ 5.10
$ 6.80
$ 4.71
NE 485,280,570
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 7.72 -0.20   898,449 $ 7.94
$ 7.70
$ 8.475
$ 6.32
5.01 1,080,282,760
OXiGENE, Inc.
OXGN: NASDAQ-CM
$ 3.0799 -0.04   23,241 $ 3.1201
$ 3
$ 9.4838
$ 3.02
NE 7,003,693
Osiris Therapeutics, Inc.
OSIR: NASDAQ-GM
$ 10.58 -0.07   15,797 $ 10.81
$ 10.47
$ 14.46
$ 6.55
NE 347,817,500
ONYX Pharmaceuticals, Inc.
ONXX: NASDAQ-GS
$ 86.18 -2.62   781,089 $ 88.80
$ 85.72
$ 101.569
$ 44
NE 6,205,477,080
Novavax, Inc.
NVAX: NASDAQ-GS
$ 1.91 -0.02   336,152 $ 1.92
$ 1.89
$ 2.77
$ 1.23
NE 282,567,310
NPS Pharmaceuticals, Inc.
NPSP: NASDAQ-GM
$ 14.71 -0.62   1,042,369 $ 15.37
$ 14.56
$ 16.47
$ 6.77
NE 1,475,898,430
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 12.95 0.25   564,088 $ 13.35
$ 12.82
$ 14.06
$ 6.72
NE 861,291,550
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 14.20 -0.21   172,826 $ 14.61
$ 14.02
$ 17.09
$ 10.05
NE 734,793,200
Medgenics, Inc.
MDGN: AMEX
$ 3.81 -0.03   3,776 $ 3.91
$ 3.81
$ 16.43
$ 3.66
NE 70,412,610
Lpath, Inc.
LPTN: NASDAQ-CM
$ 4.64 0.07   5,910 $ 4.75
$ 4.57
$ 7.01
$ 4.13
NE 60,788,640